Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-02

FDA Approved: CARISOPRODOL — Supplemental Application (Vensun Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for carisoprodol from Vensun Pharmaceuticals, Inc., marking an approved change to the product's existing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carisoprodol (Carisoprodol)

Snippet

SUPPL AP for CARISOPRODOL (CARISOPRODOL)